Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Cel-Sci - 30 Year Stock Price History | CVM

Historical daily share price chart and data for Cel-Sci since 1991 adjusted for splits. The latest closing stock price for Cel-Sci as of September 17, 2021 is 12.16.
  • The all-time high Cel-Sci stock closing price was 11800.00 on November 07, 1991.
  • The Cel-Sci 52-week high stock price is 40.91, which is 236.4% above the current share price.
  • The Cel-Sci 52-week low stock price is 7.08, which is 41.8% below the current share price.
  • The average Cel-Sci stock price for the last 52 weeks is 15.42.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Cel-Sci Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 16.3553 12.0000 27.6400 7.6400 12.1600 4.29%
2020 13.0443 9.0900 17.6000 7.5400 11.6600 27.43%
2019 6.1802 2.8900 9.6000 2.5800 9.1500 218.82%
2018 2.3678 1.8600 4.2600 0.8297 2.8700 51.87%
2017 2.2183 1.7725 3.9750 1.5900 1.8898 12.49%
2016 10.5651 10.0000 15.8750 1.6800 1.6800 -81.84%
2015 17.7444 15.4725 29.7500 9.2400 9.2500 -36.32%
2014 25.5468 16.2500 45.7500 13.5000 14.5250 -1.84%
2013 50.2212 69.3750 73.7500 14.1950 14.7975 -78.08%
2012 93.9612 75.0000 147.5000 67.5000 67.5000 -6.86%
2011 127.6821 206.6250 207.8750 68.7500 72.4750 -64.69%
2010 160.9908 230.0000 257.5000 112.5000 205.2500 -8.78%
2009 159.6703 77.5000 482.5000 37.5000 225.0000 215.79%
2008 134.3996 132.4750 175.0000 45.0000 71.2500 -44.11%
2007 172.5876 145.0000 240.0000 125.0000 127.4750 -8.95%
2006 189.1336 122.5250 432.5000 122.5000 140.0000 14.29%
2005 145.2032 157.5000 240.0000 112.5000 122.5000 -18.33%
2004 208.7817 287.5000 345.0000 117.5000 150.0000 -43.40%
2003 171.1012 52.5000 420.0000 42.5000 265.0000 404.76%
2002 95.8284 237.5000 292.5000 45.0000 52.5000 -77.89%
2001 356.6734 440.0000 712.5000 197.5000 237.5000 -36.67%
2000 885.1696 577.5000 3000.0000 265.0000 375.0000 -35.06%
1999 576.5972 407.5000 952.5000 407.5000 577.5000 32.00%
1998 972.5595 1547.5000 1595.0000 390.0000 437.5000 -73.56%
1997 1257.4605 1092.5000 2500.0000 717.5000 1655.0000 55.76%
1996 1513.7697 845.0000 3235.0000 672.5000 1062.5000 18.38%
1995 1047.6687 1250.0000 1875.0000 610.0000 897.5000 -12.44%
1994 2256.8452 4075.0000 4450.0000 850.0000 1025.0000 -71.53%
1993 3761.4625 4525.0000 4925.0000 3050.0000 3600.0000 -24.61%
1992 5109.4488 7275.0000 9150.0000 2825.0000 4775.0000 -40.13%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.523B $0.001B
CEL-SCI CORP. was formed to acquire and finance research and development of natural human interleukin-2 (``IL-2``) and lymphokine-related products and processes using the Co.'s proprietary cell culture technologies. The Co.'s proprietary product is sometimes referred to as MULTIKINEn, or buffy-coat interleukins, which is a combination, or ``cocktail`` of IL-2 and certain lymphokines and cytokines. MULTIKINE is a trade name of Co. Since its inception the focus of the Co.'s product development efforts has been on conducting clinical trials to test its proprietary technologies.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $173.588B 53.62
Bristol Myers Squibb (BMY) United States $136.238B 9.07
Amgen (AMGN) United States $124.575B 13.49
CSL (CSLLY) Australia $102.379B 0.00
Gilead Sciences (GILD) United States $89.785B 8.68
BioNTech SE (BNTX) Germany $87.107B 18.80
Regeneron Pharmaceuticals (REGN) United States $69.722B 11.97
Illumina (ILMN) United States $65.576B 74.50
Vertex Pharmaceuticals (VRTX) United States $48.850B 18.98
Biogen (BIIB) United States $44.738B 12.28
BeiGene (BGNE) Cayman Islands $37.507B 0.00
Seagen (SGEN) United States $28.420B 47.92
Genmab (GMAB) Denmark $28.322B 69.55
Genmab (GNMSF) Denmark $27.553B 68.87
Horizon Therapeutics Public (HZNP) Ireland $24.783B 23.49
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $22.621B 0.00
Bio-Techne Corp (TECH) United States $20.882B 93.91
Exact Sciences (EXAS) United States $18.596B 0.00
Novavax (NVAX) United States $17.693B 0.00
ARGENX SE-ADR (ARGX) Netherlands $17.061B 0.00
Repligen (RGEN) United States $16.850B 128.41
Incyte (INCY) United States $16.781B 39.78
BioMarin Pharmaceutical (BMRN) United States $14.257B 102.32
Guardant Health (GH) United States $13.376B 0.00
QIAGEN (QGEN) Netherlands $12.389B 20.98
Zai Lab (ZLAB) China $12.273B 0.00
Intellia Therapeutics (NTLA) United States $11.559B 0.00
CureVac (CVAC) Germany $10.301B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.489B 24.37
Ascendis Pharma (ASND) Denmark $9.109B 0.00
Mirati Therapeutics (MRTX) United States $8.985B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.829B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.417B 30.17
Acceleron Pharma (XLRN) United States $8.380B 0.00
Vir Biotechnology (VIR) United States $7.124B 0.00
Sarepta Therapeutics (SRPT) United States $6.897B 0.00
Beam Therapeutics (BEAM) United States $6.828B 0.00
Fate Therapeutics (FATE) United States $6.815B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.666B 0.00
Exelixis (EXEL) United States $6.528B 71.45
Denali Therapeutics (DNLI) United States $6.426B 182.17
Legend Biotech (LEGN) United States $6.343B 0.00
Blueprint Medicines (BPMC) United States $6.209B 17.52
Twist Bioscience (TWST) United States $6.001B 0.00
Halozyme Therapeutics (HALO) United States $5.984B 24.44
NeoGenomics (NEO) United States $5.942B 805.33
I-Mab (IMAB) China $5.838B 0.00
AbCellera Biologics (ABCL) $5.674B 0.00
Adaptive Biotechnologies (ADPT) United States $5.595B 0.00
Certara (CERT) United States $5.464B 0.00
Alkermes (ALKS) Ireland $4.858B 143.38
Arvinas (ARVN) United States $4.746B 0.00
Editas Medicine (EDIT) United States $4.314B 0.00
Reata Pharmaceuticals (RETA) United States $4.000B 0.00
Arena Pharmaceuticals (ARNA) United States $3.729B 0.00
SpringWorks Therapeutics (SWTX) United States $3.675B 0.00
Galapagos (GLPG) Belgium $3.646B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.484B 0.00
Prothena (PRTA) Ireland $3.405B 0.00
Kymera Therapeutics (KYMR) United States $3.213B 0.00
ALX Oncology Holdings (ALXO) United States $3.139B 0.00
Insmed (INSM) United States $3.086B 0.00
Emergent Biosolutions (EBS) United States $3.068B 7.40
Apellis Pharmaceuticals (APLS) United States $2.976B 0.00
Amicus Therapeutics (FOLD) United States $2.932B 0.00
Cytokinetics (CYTK) United States $2.830B 0.00
Intra-Cellular Therapies (ITCI) United States $2.795B 0.00
Heska (HSKA) United States $2.777B 532.37
ACADIA Pharmaceuticals (ACAD) United States $2.683B 0.00
Myriad Genetics (MYGN) United States $2.632B 0.00
Arcus Biosciences (RCUS) United States $2.598B 0.00
Instil Bio (TIL) United States $2.544B 0.00
Celldex Therapeutics (CLDX) United States $2.528B 0.00
Morphic Holding (MORF) United States $2.460B 0.00
Sorrento Therapeutics (SRNE) United States $2.459B 0.00
C4 Therapeutics (CCCC) United States $2.420B 0.00
Ligand Pharmaceuticals (LGND) United States $2.414B 35.30
Vericel (VCEL) United States $2.410B 287.17
Seer (SEER) $2.288B 0.00
Atea Pharmaceuticals (AVIR) United States $2.171B 0.00
Alector (ALEC) United States $2.168B 0.00
Myovant Sciences (MYOV) United Kingdom $2.102B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.097B 35.72
Amarin (AMRN) Ireland $2.036B 515.00
Revance Therapeutics (RVNC) United States $2.000B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.988B 0.00
Castle Biosciences (CSTL) United States $1.946B 0.00
REGENXBIO (RGNX) United States $1.919B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.914B 0.00
Berkeley Lights (BLI) United States $1.819B 0.00
NGM Biopharmaceuticals (NGM) United States $1.781B 0.00
Global Blood Therapeutics (GBT) United States $1.749B 0.00
Inovio Pharmaceuticals (INO) United States $1.712B 0.00
Dynavax Technologies (DVAX) United States $1.709B 0.00
PHARMA MAR SA (PHMMF) Spain $1.699B 0.00
UniQure (QURE) Netherlands $1.696B 5.77
Dicerna Pharmaceuticals (DRNA) United States $1.680B 0.00
Zymeworks (ZYME) Canada $1.654B 0.00
Codexis (CDXS) United States $1.654B 0.00
MorphoSys AG (MOR) Germany $1.643B 0.00
Nurix Therapeutics (NRIX) United States $1.599B 0.00
Ocugen (OCGN) United States $1.576B 0.00
Bionano Genomics (BNGO) United States $1.552B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.536B 0.00
Kadmon Holdings (KDMN) United States $1.505B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.478B 0.00
Genetron Holdings (GTH) China $1.463B 0.00
MaxCyte (MXCT) United States $1.442B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.434B 0.00
PureTech Health (PRTC) United States $1.413B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.408B 0.00
Inhibrx (INBX) United States $1.403B 0.00
Scholar Rock Holding (SRRK) United States $1.396B 0.00
Sangamo Therapeutics (SGMO) United States $1.388B 0.00
Zealand Pharma (ZEAL) Denmark $1.381B 0.00
Travere Therapeutics (TVTX) United States $1.367B 0.00
Agenus (AGEN) United States $1.359B 0.00
Coherus BioSciences (CHRS) United States $1.343B 0.00
Avid Bioservices (CDMO) United States $1.287B 262.25
Fulcrum Therapeutics (FULC) United States $1.242B 0.00
Bluebird Bio (BLUE) United States $1.238B 0.00
Repare Therapeutics (RPTX) Canada $1.169B 0.00
BioAtla (BCAB) United States $1.168B 0.00
RAPT THERAPTICS (RAPT) United States $1.164B 0.00
Precigen (PGEN) United States $1.132B 0.00
MannKind (MNKD) United States $1.131B 0.00
Northwest Biotherapeutics (NWBO) United States $1.129B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.124B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.114B 0.00
ImmunityBio (IBRX) United States $1.113B 0.00
Absci (ABSI) United States $1.108B 0.00
IDEAYA Biosciences (IDYA) United States $1.032B 0.00
Nkarta (NKTX) United States $1.030B 0.00
Prometheus Biosciences (RXDX) United States $1.016B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Merus (MRUS) Netherlands $0.986B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.963B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.943B 29.22
Immatics (IMTX) Germany $0.921B 0.00
Sutro Biopharma (STRO) United States $0.908B 0.00
Avidity Biosciences (RNA) United States $0.903B 0.00
BeyondSpring (BYSI) United States $0.896B 0.00
VBI Vaccines (VBIV) United States $0.847B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.843B 0.00
Protagonist Therapeutics (PTGX) United States $0.834B 0.00
Mesoblast (MESO) Australia $0.800B 0.00
Shattuck Labs (STTK) United States $0.799B 0.00
Akoya Biosciences (AKYA) United States $0.780B 0.00
Curis (CRIS) United States $0.777B 0.00
Precision BioSciences (DTIL) United States $0.766B 0.00
Cara Therapeutics (CARA) United States $0.764B 95.31
Amryt Pharma (AMYT) United Kingdom $0.760B 0.00
AnaptysBio (ANAB) United States $0.739B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.734B 0.00
Keros Therapeutics (KROS) United States $0.717B 0.00
Mersana Therapeutics (MRSN) United States $0.710B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.702B 12.79
MiMedx (MDXG) United States $0.688B 0.00
Adagene (ADAG) China $0.663B 0.00
G1 THERAPEUTICS (GTHX) United States $0.659B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.657B 0.00
Cellectis S.A (CLLS) France $0.656B 0.00
Pliant Therapeutics (PLRX) United States $0.656B 0.00
Seres Therapeutics (MCRB) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Innate Pharma S.A (IPHA) France $0.641B 0.00
Affimed (AFMD) Germany $0.628B 0.00
Pharming Group (PHAR) Netherlands $0.627B 0.00
Spero Therapeutics (SPRO) United States $0.616B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
MeiraGTx Holdings (MGTX) United States $0.599B 0.00
ALBIREO PHARMA (ALBO) United States $0.593B 0.00
Epizyme (EPZM) United States $0.586B 0.00
Ambrx Biopharma (AMAM) United States $0.580B 0.00
VistaGen Therapeutics (VTGN) United States $0.575B 0.00
Clovis Oncology (CLVS) United States $0.573B 0.00
Anika Therapeutics (ANIK) United States $0.572B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.572B 0.00
Bolt Biotherapeutics (BOLT) United States $0.569B 0.00
Gritstone Bio (GRTS) United States $0.569B 0.00
DBV Technologies S.A (DBVT) France $0.562B 0.00
Vaccitech (VACC) United Kingdom $0.549B 0.00
Inventiva S.A (IVA) France $0.537B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.529B 0.00
Selecta Biosciences (SELB) United States $0.512B 0.00
AC Immune SA (ACIU) Switzerland $0.508B 0.00
Verastem (VSTM) United States $0.499B 0.00
Clene (CLNN) United States $0.495B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
XBiotech (XBIT) United States $0.488B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.487B 0.00
Bellus Health (BLU) Canada $0.472B 0.00
ChromaDex (CDXC) United States $0.462B 0.00
Compugen (CGEN) Israel $0.459B 0.00
Geron (GERN) United States $0.452B 0.00
Arbutus Biopharma (ABUS) United States $0.431B 0.00
Codiak BioSciences (CDAK) United States $0.427B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.425B 0.00
Oncobiologics (OTLK) United States $0.423B 0.00
Starpharma Holdings (SPHRY) Australia $0.412B 0.00
Cue Biopharma (CUE) United States $0.407B 0.00
SQZ Biotechnologies (SQZ) United States $0.406B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.406B 0.00
Clearside Biomedical (CLSD) United States $0.403B 0.00
BioDelivery Sciences (BDSI) United States $0.393B 12.09
ZIOPHARM Oncology Inc (ZIOP) United States $0.392B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.390B 0.00
Athenex (ATNX) United States $0.383B 0.00
ANI Pharmaceuticals (ANIP) United States $0.369B 10.07
Aeglea BioTherapeutics (AGLE) United States $0.367B 0.00
Cogent Biosciences (COGT) United States $0.358B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.354B 0.00
Neoleukin Therapeutics (NLTX) United States $0.350B 0.00
Theratechnologies (THTX) Canada $0.342B 0.00
CytomX Therapeutics (CTMX) United States $0.341B 0.00
Fortress Biotech (FBIO) United States $0.339B 0.00
Prima BioMed (IMMP) Australia $0.334B 0.00
Opthea (OPT) Australia $0.333B 0.00
Athersys (ATHX) United States $0.333B 0.00
INmune Bio (INMB) United States $0.327B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.318B 0.00
Syros Pharmaceuticals (SYRS) United States $0.315B 0.00
Angion Biomedica (ANGN) United States $0.313B 0.00
AquaBounty Technologies (AQB) United States $0.313B 0.00
XOMA (XOMA) United States $0.290B 122.19
WAVE Life Sciences (WVE) Singapore $0.288B 0.00
Puma Biotechnology (PBYI) United States $0.281B 0.00
Beyond Air (XAIR) United States $0.278B 0.00
Checkpoint Therapeutics (CKPT) United States $0.278B 0.00
Cardiff Oncology (CRDF) United States $0.271B 0.00
Kaleido Biosciences (KLDO) $0.248B 0.00
Frequency Therapeutics (FREQ) United States $0.247B 0.00
Kamada (KMDA) Israel $0.239B 19.89
AVEO Pharmaceuticals (AVEO) United States $0.237B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.234B 0.00
Adicet Bio (ACET) United States $0.229B 0.00
OVID THERAPEUTC (OVID) United States $0.229B 2.01
Adverum Biotechnologies (ADVM) United States $0.227B 0.00
Trevena (TRVN) United States $0.224B 0.00
Seelos Therapeutics (SEEL) United States $0.205B 0.00
Kala Pharmaceuticals (KALA) United States $0.203B 0.00
TELA Bio (TELA) United States $0.197B 0.00
NextCure (NXTC) United States $0.193B 0.00
ObsEva SA (OBSV) Switzerland $0.192B 0.00
Talis Biomedical (TLIS) United States $0.185B 0.00
OSMOTICA PHARM (OSMT) United States $0.180B 0.00
SESEN BIO, INC (SESN) United States $0.178B 0.00
CorMedix Inc (CRMD) United States $0.178B 0.00
GENFIT S.A (GNFT) France $0.177B 0.00
HOOKIPA Pharma (HOOK) United States $0.176B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71
ATyr Pharma (LIFE) United States $0.174B 0.00
Synlogic (SYBX) United States $0.172B 0.00
ADMA Biologics Inc (ADMA) United States $0.171B 0.00
Aptinyx (APTX) United States $0.168B 0.00
Galena Biopharma (SLS) United States $0.167B 0.00
Erytech Pharma SA (ERYP) France $0.164B 0.00
Catalyst Biosciences (CBIO) United States $0.162B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
Leap Therapeutics (LPTX) United States $0.158B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.157B 0.00
Biofrontera AG (BFRA) Germany $0.156B 0.00
Dyadic (DYAI) United States $0.151B 0.00
LogicBio Therapeutics (LOGC) United States $0.150B 0.00
TScan Therapeutics (TCRX) United States $0.150B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.147B 0.00
Applied Genetic Technologies (AGTC) United States $0.147B 0.00
Vascular Biogenics (VBLT) Israel $0.145B 0.00
Strongbridge Biopharma (SBBP) United States $0.144B 0.00
Nicox SA (NICXF) France $0.142B 0.00
Novogen (KZIA) Australia $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.139B 0.00
Cyclerion Therapeutics (CYCN) United States $0.135B 0.00
X4 Pharmaceuticals (XFOR) United States $0.131B 0.00
Evofem Biosciences (EVFM) United States $0.130B 0.00
Purple Biotech (PPBT) Israel $0.128B 0.00
Eton Pharmaceuticals (ETON) United States $0.126B 0.00
Orgenesis (ORGS) United States $0.125B 0.00
Exicure (XCUR) United States $0.124B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.122B 0.00
Abeona Therapeutics (ABEO) United States $0.121B 0.00
Voyager Therapeutics (VYGR) United States $0.118B 6.76
Eyenovia (EYEN) United States $0.117B 0.00
Entera Bio (ENTX) Israel $0.114B 0.00
Yumanity Therapeutics (YMTX) United States $0.114B 0.00
Viridian Therapeutics (VRDN) United States $0.112B 0.00
Cidara Therapeutics (CDTX) United States $0.105B 0.00
Cocrystal Pharma (COCP) United States $0.102B 0.00
Pluristem Therapeutics (PSTI) Israel $0.096B 0.00
Aadi Bioscience (AADI) United States $0.093B 0.00
Celsion (CLSN) United States $0.092B 0.00
Emmaus Life Sciences (EMMA) United States $0.085B 0.00
Aptevo Therapeutics (APVO) United States $0.084B 0.00
Zosano Pharma (ZSAN) United States $0.084B 0.00
ARAVIVE, INC (ARAV) United States $0.084B 0.00
Lumos Pharma (LUMO) United States $0.084B 0.00
Adocia (ADOCY) France $0.083B 0.00
Statera Biopharma (STAB) United States $0.082B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.081B 0.00
Liminal BioSciences (LMNL) Canada $0.081B 0.00
Aytu BioPharma (AYTU) United States $0.079B 0.00
DiaMedica Therapeutics (DMAC) United States $0.079B 0.00
Evogene (EVGN) Israel $0.078B 0.00
Edesa Biotech (EDSA) Canada $0.078B 0.00
Advaxis (ADXS) United States $0.077B 0.00
AEterna Zentaris (AEZS) United States $0.076B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
ABVC BioPharma (ABVC) United States $0.070B 0.00
AIkido Pharma (AIKI) United States $0.070B 0.00
Longeveron (LGVN) United States $0.069B 0.00
Vyant Bio (VYNT) United States $0.069B 0.00
Celyad SA (CYAD) Belgium $0.068B 0.00
Organovo Holdings (ONVO) United States $0.066B 0.00
AnPac Bio-Medical Science (ANPC) China $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
Enveric Biosciences (ENVB) United States $0.054B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.053B 0.00
Antibe Therapeutics (ATBPF) Canada $0.053B 0.00
Acorda Therapeutics (ACOR) United States $0.053B 1.10
BioCardia (BCDA) United States $0.052B 0.00
Genetic Technologies (GENE) Australia $0.052B 0.00
Forte Biosciences (FBRX) United States $0.051B 0.00
Windtree Therapeutics (WINT) United States $0.050B 0.00
ARIDIS PHARMACT (ARDS) United States $0.049B 0.00
Vallon Pharmaceuticals (VLON) United States $0.048B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Cyclo Therapeutics (CYTH) United States $0.044B 0.00
Soligenix (SNGX) United States $0.043B 0.00
Invo BioScience (INVO) United States $0.037B 0.00
Palisade Bio (PALI) United States $0.035B 0.00
Happiness Biotech Group (HAPP) China $0.035B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
Benitec Biopharma (BNTC) United States $0.032B 0.00
GeoVax Labs (GOVX) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.027B 0.00
ZIVO Bioscience (ZIVO) United States $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.016B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00